E-Cadherin/ROS1 Inhibitor Synthetic Lethality in Breast Cancer. (2018)

First Author: Bajrami I

Attributed to: King's Health Partners Confidence in Concept funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/2159-8290.cd-17-0603

PubMed Identifier: 29610289

Publication URI: http://europepmc.org/abstract/MED/29610289

Type: Journal Article/Review

Volume: 8

Parent Publication: Cancer discovery

Issue: 4

ISSN: 2159-8274